1. Home
  2. CPRX vs WOR Comparison

CPRX vs WOR Comparison

Compare CPRX & WOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • WOR
  • Stock Information
  • Founded
  • CPRX 2002
  • WOR 1955
  • Country
  • CPRX United States
  • WOR United States
  • Employees
  • CPRX N/A
  • WOR N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • WOR Aerospace
  • Sector
  • CPRX Health Care
  • WOR Consumer Discretionary
  • Exchange
  • CPRX Nasdaq
  • WOR Nasdaq
  • Market Cap
  • CPRX 2.9B
  • WOR 3.0B
  • IPO Year
  • CPRX 2006
  • WOR N/A
  • Fundamental
  • Price
  • CPRX $20.78
  • WOR $62.77
  • Analyst Decision
  • CPRX Strong Buy
  • WOR Buy
  • Analyst Count
  • CPRX 6
  • WOR 3
  • Target Price
  • CPRX $32.83
  • WOR $63.67
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • WOR 356.1K
  • Earning Date
  • CPRX 08-06-2025
  • WOR 06-24-2025
  • Dividend Yield
  • CPRX N/A
  • WOR 1.06%
  • EPS Growth
  • CPRX 178.13
  • WOR N/A
  • EPS
  • CPRX 1.57
  • WOR 1.92
  • Revenue
  • CPRX $534,645,999.00
  • WOR $1,153,762,000.00
  • Revenue This Year
  • CPRX $16.37
  • WOR $3.23
  • Revenue Next Year
  • CPRX $8.80
  • WOR $4.45
  • P/E Ratio
  • CPRX $13.34
  • WOR $33.31
  • Revenue Growth
  • CPRX 29.97
  • WOR N/A
  • 52 Week Low
  • CPRX $15.34
  • WOR $37.88
  • 52 Week High
  • CPRX $26.58
  • WOR $70.91
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 38.36
  • WOR 53.96
  • Support Level
  • CPRX $20.62
  • WOR $62.54
  • Resistance Level
  • CPRX $22.10
  • WOR $65.05
  • Average True Range (ATR)
  • CPRX 0.60
  • WOR 2.11
  • MACD
  • CPRX 0.06
  • WOR -0.23
  • Stochastic Oscillator
  • CPRX 50.34
  • WOR 25.00

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.

Share on Social Networks: